Would you take a drug discovered by artificial intelligence?

The British startup Exscientia claims it has developed the first medication created using artificial intelligence that will be clinically tested on humans. The medication, which is meant to treat obsessive-compulsive disorder, took less than a year from conception to trial-ready capsule. Human trials are set to begin in March, but would you take a drug designed using artificially intelligent software? The appeal of AI-designed drugs is relatively straightforward. There are lots and lots of possible molecules that might be useful in medications, far too many for all the medical researchers in the world to manually test.